No Data
Express News | Today's stocks have shown unusual movements, with Block Orders selling off electronic and computer stocks | 【Large Amplitude
Express News | Hainan Poly Pharm: Won the bid for the tenth batch of national pharmaceutical centralized procurement.
December 10 A-share investment risk avoidance | Shenzhen SDG Service: Shareholder Silver Kun Company and Longxin Construction plan to collectively shareholding not exceeding 2%.
Hainan Poly Pharm: Currently under investigation by the Securities Regulatory Commission. There is a risk of being subjected to compulsory delisting due to major illegal activities involving stocks.
A-share anomaly | Hainan Poly Pharm plunges 14% at the beginning of the day, may face the risk of being (delisted) forcibly.
On December 3, Gelonghui reported that hainan poly pharm (300630.SZ) significantly dropped by 14% at the beginning of the session, now at 10.68 yuan, with the decline narrowed to 8.6%, and the total market value fell below 5 billion yuan. In the news, last night the company disclosed again the 'Announcement on the Progress of the Case Investigation and Risk Warning,' indicating the risk of being subjected to major illegal forced (delisted). Additionally, according to relevant regulations, if the company's stocks are terminated from listing, the convertible bonds issued by the company will also be simultaneously terminated from listing or trading. (Gelonghui)
Express News | Hainan Poly Pharm: The company is suspected of violating information disclosure regulations and is currently under investigation by the China Securities Regulatory Commission.
Express News | Hainan Poly Pharm: The innovative drug injection PL002 has received clinical trial approval in China.
No Data
